Stay updated with breaking news from 91307c10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) have been assigned an average rating of “Moderate Buy” from the nine analysts that are currently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a sell rating and seven have issued a buy rating on the company. The average 1-year price […]
StockNews.com downgraded shares of United Therapeutics (NASDAQ:UTHR – Free Report) from a strong-buy rating to a buy rating in a report issued on Friday morning. Several other research firms also recently weighed in on UTHR. LADENBURG THALM/SH SH lowered their price objective on shares of United Therapeutics from $285.00 to $256.00 in a report on […]
Victory Capital Management Inc. increased its stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Get Rating) by 32.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 28,671 shares of the biotechnology company’s stock after acquiring an additional 7,046 shares during […]
United Therapeutics Co. (NASDAQ:UTHR – Get Rating) EVP Paul A. Mahon sold 6,000 shares of the firm’s stock in a transaction dated Thursday, June 15th. The stock was sold at an average price of $227.77, for a total transaction of $1,366,620.00. Following the sale, the executive vice president now owns 36,599 shares of the company’s […]
Roundview Capital LLC trimmed its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Get Rating) by 53.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,886 shares of the biotechnology company’s stock after selling 2,195 shares during […]